No Data
Sumitomo Pharma Announces Reversal of Doubtful Accounts Allowance
Sumitomo Pharma Boosts Financial Forecasts and Records Gains From Equity Transfers
Sumitomo Pharma: Interim report.
Sumitomo Pharma: Notice regarding revisions to earnings forecasts and recording of transfer gains
The Nikkei average rose by about 505 yen, with the top gainers among the adopted stocks being Nidec Corporation Sponsored ADR, Renesas, and Fujikura ETC.
On the 25th, around 11 AM, the Nikkei average stock price is trending at around 35,545 yen, up about 505 yen compared to the previous day. At 9:38 AM, it reached 35,654 yen and 24 sen, up 615 yen and 9 sen. After that, lacking any guiding materials, it has been under pressure from selling as it waits for a rebound. The dollar-yen exchange rate is around 143 yen per dollar, showing a depreciation of the yen compared to the morning level. Among the stocks adopted by the Nikkei index, Nidec Corporation Sponsored ADR <6594.T>, Renesas <6723.T>, and others are among the top gainers.
Obic, JT, ETC (additional) Rating
Upgraded - Bullish Code Stock Name Securities Company Previous After ---------------------------------------------------- <7013> IHI City "2" "1" Target Price Change Code Stock Name Securities Company Previous After ---------------------------------------------------- <2914> JT Morgan S 4550 yen 4600 yen <4506> Sumitomo Pharma.
